The Global Dietary Supplements Market is Segmented by Type (Botanicals, Vitamins, Minerals, Amino Acids, Probiotic), by Application (Health Care…
Blog
Dilated Cardiomyopathy Market to Boost at a CAGR of approximately 13% by 2032 | DelveInsight
DelveInsight’s Dilated Cardiomyopathy Market Insights report includes a comprehensive understanding of current treatment practices, dilated cardiomyopathy emerging drugs,…
Europe Cervical Cancer Screening Market Report 2022: Raising Awareness and Government Legislation Presents Opportunities
The “Europe Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Growth, Outlooks, Impact of COVID-19, Company…
KSA Fitness Equipment Market is expected to expand at a CAGR of ~18.7% on the basis of Revenue in between 2021-2026: Ken Research
March 2022 Launch and expansion of approximately 163 hotel projects such as Radisson and Hyatt as…
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and GO Therapeutics, Inc. (Co-Founder and…
With Market Size Valued at $250.3 Billion by 2026, it`s a Healthy Outlook for the Global Active Pharmaceutical Ingredients (API) Market
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company,…
GTS VirtualHealth Platform designated FedRAMP In-Process Status
Global Telehealth Services (GTS), an industry leading Remote Patient Monitoring (RPM) company, today announced that the…
Biden Calls Effort to Vaccinate Very Young U.S. Children a ‘Monumental Step Forward’
President Biden on Tuesday marked what White House officials have cast as the unofficial beginning of the U.S.…
Connected Gym Equipment Market to Grow at a CAGR of 27% by 2025|Cardiovascular Training Equipment Segment to be Significant for Revenue Generation|17000+ Technavio Reports
The connected gym equipment market share is expected to increase by USD 11.12 billion from 2020 to 2025,…
Rakuten Medical Taiwan Announces Commencing a Phase 2 Clinical Trial for Head and Neck Squamous Cell Carcinoma Photoimmunotherapy based on the Alluminox™ platform at 5 Leading Medical Centers and the Enrollment of First Patient
Rakuten Medical Taiwan, Inc. today announced that their ASP-1929 Photoimmunotherapy Phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT05265013)…